Skadden advised Trip.com Group Limited, while Latham & Watkins advised the initial purchasers on the transaction. Trip.com Group Limited (“Trip.com Group”), a leading one-stop travel service...
Trip.com Group’s US$1.5 Billion Convertible Senior Notes Offering
MicroTech Medical’s US$249 Million Initial Public Offering
Davis Polk advised MicroTech Medical, while Clifford Chance has advised the joint sponsors involved in the transaction. The Hangzhou-based firm offers diabetes therapy and manufactures medical...
Kindstar Globalgene Technology’s US$285.2 Million IPO
S&C acted as Hong Kong and U.S. counsel to the joint sponsors and underwriters, including Goldman Sachs, CICC and Credit Suisse. Davis Polk advised Kindstar Globalgene...
Nayuki’s $655 Million Initial Public Offering
Kirkland & Ellis advised the sponsors and underwriters on the initial public offering of Nayuki Holdings Limited, assisted by Walkers and Davis Polk & Wardwell. Other...
Zylox-Tonbridge’s US$330 Million IPO and Listing on the Hong Kong Stock Exchange
Davis Polk advised Zylox-Tonbridge Medical Technology Co., Ltd., while Clifford Chance has advised Morgan Stanley, CLSA and other underwriters. Grandall Advised Zylox-Tonbridge. JunHe advised Zylox-Tonbridge. The...
CARsgen Therapeutics Holdings Limited’s Listing on the Stock Exchange of Hong Kong
Davis Polk and Maples and Calder advised CARsgen Therapeutics Holdings Limited, while Herbert Smith Freehills and Zhong Lun advised Goldman Sachs and UBS on the deal....